AU5968600A - Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses - Google Patents

Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses

Info

Publication number
AU5968600A
AU5968600A AU59686/00A AU5968600A AU5968600A AU 5968600 A AU5968600 A AU 5968600A AU 59686/00 A AU59686/00 A AU 59686/00A AU 5968600 A AU5968600 A AU 5968600A AU 5968600 A AU5968600 A AU 5968600A
Authority
AU
Australia
Prior art keywords
leukemic
cell line
murine leukemia
leukemia viruses
dog cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59686/00A
Inventor
Antoine Corbine
Jean-Luc Darlix
Imene Ghernati
Dominique Rigal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Francais du Sang Ets
Original Assignee
Francais du Sang Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99401199A external-priority patent/EP1061129A1/en
Application filed by Francais du Sang Ets filed Critical Francais du Sang Ets
Publication of AU5968600A publication Critical patent/AU5968600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU59686/00A 1999-05-17 2000-05-17 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses Abandoned AU5968600A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP99401192 1999-05-17
EP99401192 1999-05-17
EP99401199 1999-05-18
EP99401199A EP1061129A1 (en) 1999-05-18 1999-05-18 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
PCT/EP2000/004467 WO2000070024A2 (en) 1999-05-17 2000-05-17 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses

Publications (1)

Publication Number Publication Date
AU5968600A true AU5968600A (en) 2000-12-05

Family

ID=26153662

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59686/00A Abandoned AU5968600A (en) 1999-05-17 2000-05-17 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses

Country Status (2)

Country Link
AU (1) AU5968600A (en)
WO (1) WO2000070024A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6811480B2 (en) * 2017-02-28 2021-01-13 日本全薬工業株式会社 Canine cutaneous T cell lymphoma cell line

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244797B1 (en) * 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
FR2753203B1 (en) * 1996-09-10 1998-10-16 Transfusion Sanguine De Lyon E CONTINUOUS T LYMPHOCYTARY LINE FOR DOGS PRODUCING RETROVIRAL PARTICLES DCL 01

Also Published As

Publication number Publication date
WO2000070024A2 (en) 2000-11-23
WO2000070024A3 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU5927999A (en) A routing arrangement
AU6359900A (en) Circular saw with bevel angle adjustment mechanism
AU4426399A (en) Novel antiviral compounds
AU2430801A (en) Secure gateway having routing feature
AU2150900A (en) Hiv-specific t-cell induction
EP1214225A4 (en) A pivot with a detent
AU5011900A (en) Latch mechanism
AU6204899A (en) Novel imidazoles with anti-inflammatory activity
AU5968600A (en) Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
AUPQ171099A0 (en) Improvements to vacuum formed indexable lightweight, recyclable trays
AU6395398A (en) A composition for administration by the intranasal, sublingual or vaginal route
AU1254201A (en) Longitudinally divided loudspeaker port with increased aerodynamic efficiency
AU1892501A (en) Collector type writing implement
AU5465899A (en) Pseudotyped retroviruses and stable cell lines for their production
AU6987800A (en) Bisplatinum complexes active through the oral route
AU7447500A (en) Acylsulfonamide derivatives
ZA200004983B (en) Lightweight draft arm.
AU1892201A (en) Collector type writing implement
AU2173399A (en) Flat torch
AU3953100A (en) Pollution boom
AU1658401A (en) Boron compounds and complexes as anti-inflammatory agents
AU6805900A (en) Telecommunication mast with telecommunication means
AU5086400A (en) Improved retroviral production
AU5492899A (en) The use of loop diuretics for hiv infection
AUPQ166799A0 (en) Attachments to a flexible rule

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase